Skip to content
Menu
Network
Sub-Menu
Browse by Subject
Browse by Publisher
Join the Network
Get Started
Subscribe
Support
Contact
Search
Close
Enter Search Terms
Search
Sharon Lindan Mayl
ID:
1b83bd97-2619-30fb-68c4
/
Unclaimed
/
Organization:
DLA Piper
Published Works
3 articles
HHS to DEA: Marijuana Should Be Schedule III – What This Means for The Cannabis Industry
Cultivate ·
September 6, 2023
cite
Two hemp-derived CBD bills are re-introduced despite FDA’s call for a different legislative fix
Cultivate ·
March 29, 2023
cite
FDA seems willing to make room for a drug ingredient in a supplement, but what does that mean for CBD? NAC and the Drug Exclusion Clause of 201(ff)
Cultivate ·
December 12, 2022
cite
